Showing results (131-140 of 218) with videos related to

Sort By:
Pageof 22
Blood|August 10, 2018
Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomasIrene Scarfò, Maria Ormhøj, Matthew J Frigault, et al.
Cell Stem Cell|August 5, 2022
EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activityRan Jing, Irene Scarfo, Mohamad Ali Najia, et al.
Nature Biotechnology|April 30, 2021
CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cellsKarl Petri, Weiting Zhang, Junyan Ma, et al.
Leukemia|December 20, 2023
Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7Michael C Kann, Emily M Schneider, Antonio J Almazan, et al.
The Journal of Allergy and Clinical Immunology|November 6, 2024
Association of CD19+-targeted chimeric antigen receptor (CAR) T-cell therapy with hypogammaglobulinemia, infection, and mortalityNatalia M Sutherland, Baijun Zhou, Lingxiao Zhang, et al.
Nature Biomedical Engineering|April 24, 2019
Biomanufacturing for clinically advanced cell therapiesAyesha Aijaz, Matthew Li, David Smith, et al.
Nature Medicine|March 21, 2007
CD8(+) T-cell responses to adeno-associated virus capsid in humansFederico Mingozzi, Marcela V Maus, Daniel J Hui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2025
Ibrutinib and PD-1 blockade potentiate mesothelin-targeting CAR-T cell therapy in preclinical models of pancreatic cancerAlexander Armstrong, Graziella van der Plancke, Sae Nishiguchi, et al.
Journal for Immunotherapy of Cancer|January 8, 2022
Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS)Marc Wehrli, Kathleen Gallagher, Yi-Bin Chen, et al.
Pageof 22